Both short-and long-term treatment with the direct AMP kinase activator PXL770 improves cardiac function in ZSF-1 rats.

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Acute heart failure e-posters Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

ESC 365 is supported by

ESC 365 is supported by